A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A Multi‐center, Randomized, Double‐blind, Controlled, and Parallel Phase III Study to Compare the Efficacy and Safety of GB241 (Recombinant Anti‐CD20 Human‐Mouse Chimeric Monoclonal Antibody Injection, Experimental Drug) Plus CHOP Versus Rituximab Plus CHOP in Untreated Diffuse Large B‐cell Lymphoma (DLBCL) Patients
Epistemonikos ID: 39b3cf9a7bc197d831b0555bb48dc6696848ebce
First added on: May 21, 2024